| Melissa Cimino, LGPC | |
|
915 Rhode Island Ave Nw, Washington, DC 20001 | |
| (202) 232-6810 | |
| Not Available |
| Full Name | Melissa Cimino |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 915 Rhode Island Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003320714 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | LGPC00218 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Cimino, LGPC 915 Rhode Island Ave. Nw, Washington, DC 20001 Ph: (202) 232-6100 | Melissa Cimino, LGPC 915 Rhode Island Ave Nw, Washington, DC 20001 Ph: (202) 232-6810 |
News Archive
A recent Finnish study showed that individualised and family-based lifestyle counselling helps 6-8-year-old children increase their physical activity levels and improve their diet quality during a two-year follow-up. The results of the study conducted at the University of Eastern Finland were recently published in Preventive Medicine.
Eurotech, a leading supplier of embedded technologies, products, and systems, today announces multiple contracts with DynaVox to deliver the Catalyst LP and Catalyst Module embedded computers for the DynaVox V, Vmax and Xpress™ alternative augmentative communication (AAC) devices. The combined value of these contracts is nearly 4.2M USD, with deliveries to be made in 2010 and 2011.
Ampio Pharmaceuticals, Inc. today announced it has finalized negotiations with the directors of DMI BioSciences, Inc. (DMI) to acquire DMI BioSciences, Inc. This acquisition will give Ampio access to all rights, royalties and patents associated with DMI's major assets, drugs for male sexual dysfunction including premature ejaculation (PE) and combination drugs to treat premature ejaculation and erectile dysfunction (ED).
A drug approved by the Food and Drug Administration for melanoma in combination with a common cholesterol-lowering drug may show promise in controlling cancer growth in patients with non-small cell lung cancer (NSCLC), according to new research from the Icahn School of Medicine at Mount Sinai.
For the first time, researchers have treated an animal model of a genetic disorder using a viral vector to deliver genome-editing components in which the disease- causing mutation has been corrected.
› Verified 1 days ago
Ms. Cassaundra Janiece Wilkins, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3861 Alabama Ave Se, Washington, DC 20020 Phone: 202-645-4488 Fax: 202-645-4590 | |
Ms. Pauline Imbrigato, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1012 14th St Nw, Suite 1025, Washington, DC 20005 Phone: 202-737-6000 Fax: 202-737-2332 | |
Giovanna Ysabela Dilauro, MS, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1110 Lamont St Nw, Washington, DC 20010 Phone: 407-731-4581 | |
Joseph Martinez-williams, Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Q St Ne, Washington, DC 20002 Phone: 202-674-2256 | |
Elyse Figueroa, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2812 Erie St Se Apt B34, Washington, DC 20020 Phone: 646-744-4458 | |
Lili Johnson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 441 21st St Ne, Washington, DC 20002 Phone: 202-341-6761 |